National Adult Vaccination Program - Publications, Fact Sheets, Decision Tools, and Infographics
Article Index
Page 2 of 6
Looking for GSA's COVID-19 Updates page? Click here.
Publications
- Vaccines for Older Adults: Overcoming the Challenges of Shared Clinical Decision Making
- Charting a Path to Increase Immunization Rates in the Post-Acute and Long-term Care Setting
- Aging and Immunity: The Important Role of Vaccines
- Addressing the Complex Impact of Immunosenescence: The Value of Vaccination
- Comprehensive Report of the 2013 National Adult Vaccination Program Summit: Developing Champions and Building a Roadmap for Action to Achieve the Healthy People 2020 Goals for Adult Vaccination
Fact Sheets
GSA, in collaboration with Gerontological Advanced Practice Nurses Association (GAPNA) and AMDA, has launched a new project focused on improving education and awareness of enhanced influenza vaccine products.
- Benefits of Enhanced Influenza Vaccine Products
- More Benefits of Enhanced Influenza Vaccine Products
- Real-World Evidence: What It Says About Enhanced Influenza Vaccine Products
- Practical Strategies for Increasing Use of Enhanced Influenza Vaccine Products Among LTCF Residents and Staff
Decision Tools
Infographics
Immune function wanes in all adults — whether healthy or sick — as they age into their fifth decade and beyond. Their bodies become less adept at recognizing and stopping pathogens, and the ability to develop and maintain immunity declines. Also known as immunosenescence, age-related decline in immunity significantly contributes to the susceptibility of older adults to serious conditions, including influenza, pneumonia, and shingles.
